Company Overview
Development, production, sale and licensing of products incorporating its patented platform technology TPM, for the pharmaceutical, skin care and animal health and nutrition industries.
| Website | www.avecho.com.au |
|---|---|
| Head Office | Clayton VIC |
| Registry | Computershare Investor Services Pty Ltd |
| CEO | Paul Gavin |
| Chair Person | Gregory (Greg) Collier |
| GICS Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Sub Industry | Pharmaceuticals |
| Sector | Health Care |
| Market Cap | $18 m |
|---|---|
| Shares on Issue | 1,837 b |
| Status | Trading |
| Last Price | |
| Change | |
| 52 Week H/L | |
| VWAP | |
| Bid/Ask |
Directors and Management
Dr Gregory (Greg) Collier
Non-Executive Chairman,Non-Executive Director 30/04/2019
Dr Collier has more than 20 years' experience spanning operational, clinical and scientific aspects of pharmaceutical research, development and commercialisation. He has led the planning and execution of multiple commercial transactions including in and out licensing deals and major M&A activities, and he has taken a drug from discovery through to regulatory approval. Dr Collier was the inaugural Alfred Deakin Professor at Deakin University, and also held positions at Melbourne University, Monash University and the University of Toronto.
BSc(Hons), PhD Male
Dr Ross Murdoch
Non-Executive Director 13/04/2015
Dr Murdoch joined Phosphagenics as CEO in January 2015 and was appointed as director in April 2015. He has more than 25 years' experience as a leader within the global healthcare, pharmaceutical and biotechnology industries. He has held senior management and executive positions in Australia, the USA and Europe, with responsibility for the strategy, development and commercialisation of products, product portfolios and the building and rebuilding of new and existing businesses. Highlights of his career include Senior Vice President at Shire Pharmaceuticals where he founded and grew both the Emerging Products Business and Haematology Business, and President and COO of Prana Biotechnology Limited based in Australia.
B.Sc, Phd (Clinical Pharmacology), PG (Health Eco) Male
Mr Matthew Patrick McNamara
Non-Executive Director 13/01/2020
Mrt McNamara has over 30 years' experience in the healthcare and medical sciences sector. In 2003, he founded BioBridge Australia, a biotechnology commercialisation advisory company and advised a number of public biotechnology / investment companies. He is presently a director of Adherium Ltd (ASX:ADR), SciCapital Pty Ltd and Grey Innovation Group Pty Ltd. He has held previous directorship in, Avita Medical Ltd, Bioxyne Ltd, and Rex Bionics Pty Ltd. He has also served as CIO of BioScience Manager Pty Ltd, was CEO of SciCapital Pty Ltd, a Life Sciences Venture Capital fund, SVP Business Development for eBioinformatics Inc, General Manager of Vistakon Pty Ltd (a Johnson & Johnson Medical franchise), and held numerous management positions in Australia with Merck & Co.
BSc(Hons -Molecular Biology),MBA Male
Top 20 Shareholders
| Name | Shares | % | |
|---|---|---|---|
| 1. | Mr Mark Gregory Kerr & Mrs Linda Marie Kerr (Lindmark Inv Staff S/F A/C) | 159,684,474 | 8.73 |
| 2. | HSBC Custody Nominees (Australia) Limited | 102,104,170 | 5.58 |
| 3. | Rosscope Pty Ltd (Ross Copeland Family A/C) | 78,921,263 | 4.32 |
| 4. | Mr Mark Gregory Kerr (Lindmark Inv Staff S/F A/C) | 67,153,797 | 3.67 |
| 5. | Melbourne Securities Corporation Limited (Horizon 3 Bioteh Fund A/C) | 45,454,545 | 2.49 |
| 6. | BNP Paribas Noms Pty Ltd (Drp) | 35,325,418 | 1.93 |
| 7. | Servbond Pty Limited (Servbond Pty Ltd S/F A/C) | 23,050,000 | 1.26 |
| 8. | Citicorp Nominees Pty Limited | 22,547,403 | 1.23 |
| 9. | Ack Pty Ltd (Markoff Super No 2 A/C) | 20,494,147 | 1.12 |
| 10. | Churchcourt Pty Limited | 20,162,500 | 1.10 |
| 11. | Kazakco Pty Ltd (Kent Family A/C) | 20,000,000 | 1.09 |
| 12. | Mr Tony Domenic Amato | 19,500,712 | 1.07 |
| 13. | Mr Ross Graham Copeland & Mrs Gina Copeland (Publicity Press S/F A/C) | 16,868,545 | 0.92 |
| 14. | Dr Maurice Arthur Trewhella & Mrs Elizabeth Trewhella (Simpetejen Super Fund A/C) | 16,000,000 | 0.87 |
| 15. | Mrs Susan Margaret Chudleigh & Mr John West Chudleigh | 15,000,000 | 0.82 |
| 16. | Bhl Pension Pty Ltd (Bhl Pension Fund A/C) | 15,000,000 | 0.82 |
| 17. | Mr Gary Dean Shaw | 15,000,000 | 0.82 |
| 18. | Mr Brandon Armon Batagol | 13,932,870 | 0.76 |
| 19. | Gold Road Orient Holdings Pty Ltd | 12,500,000 | 0.68 |
| 20. | Bagbo Pty Ltd | 11,896,159 | 0.65 |
Director Transactions
| Date | Name | Qty | Value | Direction | Notes |
|---|---|---|---|---|---|
| 10/09/2021 | Gregory (Greg) Collier | 2,250,000 | $40,500 | Expiry | Options expired. |
| 31/05/2021 | Ross Murdoch | 3,993,644 | $75,879 | Issued | Issue of options. |
| 31/05/2021 | Matthew McNamara | 3,993,644 | $75,879 | Issued | Issue of options. |
| 31/05/2021 | Gregory (Greg) Collier | 5,990,465 | $113,818 | Issued | Issue of options. |